Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06052618

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:14.263039+00:00

Published At

2026-03-12T00:00:00+00:00

Record Updated At

2026-03-12

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["KSHV Inflammatory Cytokine Syndrome (KICS)", "Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-12"

protocolSection.identificationModule.nctId

"NCT06052618"

protocolSection.identificationModule.officialTitle

"Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• KSHV Inflammatory Cytokine Syndrome (KICS) (protocolSection.conditionsModule.conditions)
• Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.